Ferring Pharmaceuticals is planning to lay off up to 500 employees, amounting to roughly 7% of its global workforce157.
The layoffs are part of a company-wide optimisation and streamlining programme aimed at shifting toward a new enterprise model15.
Ferring currently employs around 7,000 staff globally and is privately owned7.
The reorganization move is described as part of a strategy to ensure future competitiveness and operational efficiency in a changing pharma market15.
The job cuts are expected to affect global operations, though the specific regions or departments most impacted have not been detailed in public statements15.
The restructuring follows broader industry trends in cost-cutting and operational refinement among major pharmaceutical companies7.
Sources:
1. https://www.fiercepharma.com/pharma/ferring-reduce-staff-500-part-reorganization
5. https://firstwordpharma.com/story/6315855
7. https://www.fiercebiotech.com/biotech/fierce-biotech-layoff-tracker-2025